Year: 2023

Otsuka_Logo_Color_RGB

Otsuka Pharmaceutical Announces Positive Topline Results From Two Pivotal Phase 3 Trials of Centanafadine as a Treatment for Adolescents and Children With Attention-Deficit/Hyperactivity Disorder (ADHD)

Centanafadine, an investigational compound for the treatment of ADHD, demonstrated statistically significant improvements vs. placebo for the primary efficacy endpoint...

image-1-22

SHARP Corporation’s Grand 111th Anniversary Event in Singapore Merges Sincerity, Creativity, and Innovation with the Official Launch of SHARP NEC Display Products Across Asia

Experience Cutting-Edge Japanese Technology and High-Performance Displays, Redefining the Vision of Tomorrow SINGAPORE - Media OutReach - 27 October 2023...

Nidec_All_for_deams.Green_RGB-8

Nidec Announces Changes to the Press Release, “Notice Regarding Commencement of Tender Offer for Takisawa Machine Tool Co., Ltd. (Securities Code: 6121)” due to Changes in Conditions to the Tender Offer to the Company